Derek Maetzold: CEO of Castle Biosciences

from BioBoss · host Derek Maetzold

Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of artificial intelligence to improve patient outcomes.

Episode metadata supplied by the publisher feed · Published Oct 29, 2021

Embed this episode

Attribution link and audio player

Ready to play

Derek Maetzold: CEO of Castle Biosciences

0:00 38:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 38 minutes long.

When was this BioBoss episode published?

This episode was published on October 29, 2021.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!